Nifedipine, verapamil and cyclosporin A pharmacokinetics in children
- PMID: 2702114
- DOI: 10.1007/BF00858540
Nifedipine, verapamil and cyclosporin A pharmacokinetics in children
Abstract
We report two paediatric renal transplant patients in whom interaction with the calcium channel blocking agent verapamil resulted in reduced cyclosporin A (CyA) elimination. Prior therapy with another calcium channel blocking agent, nifedipine, did not affect CyA pharmacokinetics. We speculate that verapamil reduced CyA elimination in children via an effect upon the microsomal oxidase system that is independent of calcium channel activity.
Similar articles
-
The interaction of the calcium channel blockers verapamil and nifedipine with cyclosporin A in pediatric renal transplant patients.Pediatr Nephrol. 1994 Aug;8(4):408-11. doi: 10.1007/BF00856514. Pediatr Nephrol. 1994. PMID: 7947026
-
The effects of calcium channel blockers on cyclosporine and its metabolites in renal transplant recipients.Ther Drug Monit. 1990 Jul;12(4):321-8. Ther Drug Monit. 1990. PMID: 2396304
-
Cyclosporin-verapamil interaction.Br J Clin Pharmacol. 1988 Mar;25(3):402-3. doi: 10.1111/j.1365-2125.1988.tb03321.x. Br J Clin Pharmacol. 1988. PMID: 3282534 Free PMC article. No abstract available.
-
Update on calcium-channel blocking agents.Clin Pharm. 1983 Sep-Oct;2(5):403-16. Clin Pharm. 1983. PMID: 6354566 Review.
-
Calcium-channel blocking agents.Clin Pharm. 1982 Jan-Feb;1(1):17-33. Clin Pharm. 1982. PMID: 6764159 Review.
Cited by
-
The interaction of the calcium channel blockers verapamil and nifedipine with cyclosporin A in pediatric renal transplant patients.Pediatr Nephrol. 1994 Aug;8(4):408-11. doi: 10.1007/BF00856514. Pediatr Nephrol. 1994. PMID: 7947026
-
Evaluation of drug interaction between cyclosporine and lercanidipine: a descriptive study.Eur J Hosp Pharm. 2024 Oct 25;31(6):560-563. doi: 10.1136/ejhpharm-2023-003757. Eur J Hosp Pharm. 2024. PMID: 37236776
-
Pharmacological management of hypertension in paediatric patients. A comprehensive review of the efficacy, safety and dosage guidelines of the available agents.Drugs. 1994 Dec;48(6):868-87. doi: 10.2165/00003495-199448060-00004. Drugs. 1994. PMID: 7533695 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical